High dose of fluoride intake is associated with toxic effects on kidney and cardiac tissues. This study evaluated the potential protective effect of fermented rooibos tea (RTE) on sodium fluoride (NaF)-induced cardiorenal toxicity in rats. Male Wistar rats (n = 56) were randomly allocated into one of seven equal groups: control, NaF (100 mg/kg orally), NaF + RTE (2%, w/v), NaF + RTE (4%, w/v), NaF + lisinopril (10 mg/kg orally), 2% RTE, and 4% RTE. The experiment lasted for 14 days and RTE was administered to the rats as their sole source of drinking fluid. NaF induced cardiorenal toxicity indicated by elevated level of urea, creatinine, LDH, creatinine kinase-MB, and cardiac troponin I in the serum, accompanied by altered histopathology of the kidney and heart. Furthermore, levels of HO, malondialdehyde, and NO were elevated, while GSH level was depleted in the kidney and heart due to NaF intoxication. Protein levels of c-reactive protein, TNFα, IL-1B, and NF-κB were increased by NaF in the serum, kidney, and heart. RTE at 2% and 4% (w/v) reversed cardiorenal toxicity, resolved histopathological impairment, attenuated oxidative stress and inhibited formation of pro-inflammatory markers. RTE at both concentrations down-regulates the mRNA expression of NF-κB, and upregulates the mRNA expression of both IκB and IκKB, thus blocking the activation of NF-κB signaling pathway. Taken together, these results clearly suggest that the protective potential of rooibos tea against NaF-induced cardiorenal toxicity, oxidative stress, and inflammation may be associated with the modulation of the NF-κB signaling pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12012-024-09826-9DOI Listing

Publication Analysis

Top Keywords

cardiorenal toxicity
20
rooibos tea
12
oxidative stress
12
signaling pathway
12
kidney heart
12
fermented rooibos
8
toxicity oxidative
8
stress inflammation
8
wistar rats
8
naf-induced cardiorenal
8

Similar Publications

Background: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure (HF), particularly when compounded by medications like Angiotensin converting inhibitors, Angiotensin receptor blockers, and potassium sparing diuretics.

View Article and Find Full Text PDF
Article Synopsis
  • - This study analyzed adverse events (AEs) from CAR T-cell therapies using data from the FDA Adverse Event Reporting System (FAERS) between 2017 and 2024, revealing both common and unique AEs associated with different CAR T-cell products.
  • - Findings showed that the most frequently reported AEs were nervous system, immune system, and general disorders, with specific AEs like parkinsonism and cerebrovascular accidents linked to certain products (e.g., Ide-cel and Cilta-cel) but not others.
  • - The study highlights the importance of careful patient assessments and monitoring during treatment, particularly for cardiopulmonary toxicity and severe nervous system conditions, as the risks vary significantly among the different CAR T-cell
View Article and Find Full Text PDF

A Systematic Review of Uremic Toxin Concentrations and Cardiovascular Risk Markers in Pediatric Chronic Kidney Disease.

Toxins (Basel)

August 2024

Department of Cardiac Sciences and Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.

Chronic kidney disease (CKD) can lead to cardiac dysfunction in a condition known as cardiorenal syndrome (CRS). It is postulated that the accumulation of uremic toxins in the bloodstream, as a consequence of declining kidney function, may contribute to these adverse cardiac effects. While CRS in adults has been extensively studied, there is a significant knowledge gap with pediatric patients.

View Article and Find Full Text PDF

Pharmacological mechanisms involved in the diuretic activity of the ethanol-soluble fraction of Baccharis milleflora (Less.) DC. - An ethnopharmacological investigation.

J Ethnopharmacol

December 2024

Postgraduate Program in Pharmacology (UFPR), Federal University of Paraná, Curitiba, PR, Brazil; Laboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS, Brazil. Electronic address:

Ethnopharmacological Relevance: Baccharis milleflora (Less.) DC. is a plant native to Brazil that is frequently used in traditional medicine as a diuretic and antihypertensive.

View Article and Find Full Text PDF

State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications.

Am J Hypertens

October 2024

Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, La Jolla, California, USA.

Article Synopsis
  • SGLT2 inhibitors (SGLT2i) change how glucose is reabsorbed in the kidneys, leading to excess glucose being eliminated in urine, which can help protect both kidneys and heart in people with or without type 2 diabetes.
  • Clinical studies show that SGLT2i are linked to better kidney and heart health by reducing plasma volume, lowering blood urate levels, and decreasing albumin in urine.
  • The drug's effects promote better kidney function over time by lowering pressure in glomeruli, reducing oxygen demand, and may enhance blood oxygen delivery through increased red blood cell production, providing a range of protective benefits.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!